CYCLERION THERAPEUTICS INC's ticker is CYCN and the CUSIP is 23255M105. A total of 70 filers reported holding CYCLERION THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | 0.0% | 552 | 0.0% | 0.00% | – |
| Q2 2023 | $2 | -99.8% | 552 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $1,206 | -33.8% | 2,779,122 | 0.0% | 0.07% | -29.4% |
| Q4 2022 | $1,823 | -99.9% | 2,779,122 | 0.0% | 0.10% | 0.0% |
| Q3 2022 | $2,391,000 | +56.8% | 2,779,122 | 0.0% | 0.10% | +25.9% |
| Q2 2022 | $1,525,000 | -50.6% | 2,779,122 | 0.0% | 0.08% | -37.2% |
| Q1 2022 | $3,085,000 | -35.5% | 2,779,122 | 0.0% | 0.13% | -0.8% |
| Q4 2021 | $4,780,000 | -44.0% | 2,779,122 | 0.0% | 0.13% | -31.9% |
| Q3 2021 | $8,532,000 | -21.3% | 2,779,122 | 0.0% | 0.19% | -13.2% |
| Q2 2021 | $10,838,000 | +113.7% | 2,779,122 | +52.9% | 0.22% | +144.4% |
| Q1 2021 | $5,071,000 | -8.8% | 1,817,584 | 0.0% | 0.09% | -24.4% |
| Q4 2020 | $5,561,000 | -49.7% | 1,817,584 | 0.0% | 0.12% | -55.6% |
| Q3 2020 | $11,051,000 | +1.5% | 1,817,584 | -1.3% | 0.27% | -11.8% |
| Q2 2020 | $10,883,000 | +120.6% | 1,841,584 | -1.1% | 0.30% | +46.2% |
| Q1 2020 | $4,933,000 | +33.2% | 1,861,584 | +36.7% | 0.21% | +45.5% |
| Q4 2019 | $3,703,000 | -77.6% | 1,361,584 | 0.0% | 0.14% | -78.4% |
| Q3 2019 | $16,502,000 | +5.8% | 1,361,584 | 0.0% | 0.66% | +4.9% |
| Q2 2019 | $15,590,000 | – | 1,361,584 | – | 0.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 552 | $2 | 0.00% |